1 Kahari VM, Sandberrg M, Kalimo H, et al. Identificationof fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol, 1988,90:664-670. 2 Gruschwitz M, Von den Driesch P, Kellner I, et al. Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patientswith progressive systemic sclerosis. J Am Acad Dermatol, 1992,27:169-177. 3 Thomas L, Mariznne BF. Inhibition of neural crest cell attachment byintegrin antisense oligonucleotides. Science, 1993,259:692-695. 4 Tromp G, Kuivaniemi H, Stacey A, et al. Structure of a full length cDNAclone for the preproα1(Ⅰ) chain of human type Ⅰ procollagen. Biochem J, 1988,253:919-922. 5 Ala-kokko L, Kontusaari S, Baldwin CT, et al. Sturcture of cDNA clonescoding forthe entire proα1(Ⅲ) chain of human type Ⅲ procollagen. Biochem J, 1989,260:509-516. 6 Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol, 1994,152:5120-5127. 7 Majewski S, Hunzelmann N, Schirren CG, et al. Increased adhesion of fibroblastsfrom patients with scleroderma to extracelluar matrix components:in vitro modulation by IFN-γ but not by TGF-β. J Invest Dermatol, 1992,98:86-91. 8 Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agentsisthe bullet really magical? Science, 1993,261:1004-1011. 9 Akhtar S, Kole RJ, Juliano RL, et al. Stability of antisense oligodeoxynucleotide analogs in celluar extracts and sera. Life Sci, 1991,49:1793-1801. |